# OLOPATADINE HYDROCHLORIDE
> **ANDA219557** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2025-02-28
## Drug
- **FDA Application Number:** ANDA219557
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLOPATADINE HYDROCHLORIDE
- **Generic name:** OLOPATADINE HYDROCHLORIDE
- **Active ingredients:** OLOPATADINE HYDROCHLORIDE
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Over-the-counter
- **Sponsor:** GLENMARK PHARMS
- **Manufacturer:** GLENMARK THERAPEUTICS INC., USA
- **First approval:** 2025-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219557)
---
*MORVS · CC0 1.0*